Trial intelligence / Profile preview

Effects of expectations, methylphenidate and placebo on Qb Test performance in untreated adults with ADHD

2014-005045-53Phase 4Active

Sponsor
Region Västmanland
Start
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate with Placebo (2 arms). Primary endpoints: QbActivity, QbInattention and 1 more. Started Dec 2014; status: active.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2014-005045-53.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005045-53.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call